The veterinary neurodegenerative disease diagnostics market is projected to grow from USD 392.2 million in 2025 to USD 886.8 million by 2035, at a CAGR of 8.5%. Consumables will dominate with a 58.0% market share, while imaging will lead the test type segment with a 42.0% share.